by Scott Larrivee | May 1, 2023 | News
Proprietary ion source and beam technology capable of producing approximately 10 times the current global supply of Astatine-211 Updated May 4, 2023 to add presentation materials Download PDF PRESENTATION The Nusano Medical Radioisotope Production Platform: Supplying...
by Scott Larrivee | Apr 20, 2023 | News
NEW YORK – April 20, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced its co-founder and Chief Operating Officer (COO), Dr. Howard Lewin, will take part in a virtual event hosted by Truist Securities on Friday,...
by Scott Larrivee | Mar 27, 2023 | News
NEW YORK and VALENCIA, Calif. – March 27, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will present and participate in a panel discussion at Jefferies Inaugural Radiopharma Innovation Summit in New York...
by Scott Larrivee | Jan 30, 2023 | Industry News
Jan. 30, 2023 – Health Imaging reports on a new case study published indicating that radioisotope supply issues are delaying prostate cancer treatments using 177Lu-PSMA-617, commonly known as Pluvicto. The health care news source writes: Following its [2022 FDA]...
by Scott Larrivee | Jan 11, 2023 | Industry News
Jan. 11, 2023 – Citing aging infrastructure and anticipated future demand, the Welsh government is taking action to establish a stable supply of medical radioisotopes for citizens of the United Kingdom. World Nuclear News reports: The Welsh government says that, as...
